BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36920988)

  • 1. Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
    Yin S; Zhang F; Wu J; Lin T; Wang X
    PLoS Med; 2023 Mar; 20(3):e1004196. PubMed ID: 36920988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
    Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
    Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
    Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients.
    Lee J; Park JY; Huh KH; Kim BS; Kim MS; Kim SI; Ahn SH; Kim YS
    Nephrol Dial Transplant; 2017 Apr; 32(4):722-729. PubMed ID: 28339910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
    Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
    J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.
    Kim J; Chung SJ; Sinn DH; Lee KW; Park JB; Huh W; Lee JE; Jang HR; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    J Viral Hepat; 2020 Jul; 27(7):739-746. PubMed ID: 32057171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection.
    Tsai HJ; Wu MJ; Chen CH; Yang SS; Huang YH; Chang YZ; Chang HR; Lee TY
    Transpl Int; 2023; 36():11122. PubMed ID: 37125384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
    Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
    Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
    Maekawa H; Yazawa M; Koitabashi K; Imai N; Kawarazaki H; Nakazawa R; Sasaki H; Chikaraishi T; Shibagaki Y
    Transplant Proc; 2016; 48(6):2046-9. PubMed ID: 27569942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1111-1119. PubMed ID: 29845351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: A single-center experience.
    Meng C; Belino C; Pereira L; Pinho A; Sampaio S; Tavares I; Bustorff M; Sarmento A; Pestana M
    Nefrologia (Engl Ed); 2018; 38(5):545-550. PubMed ID: 29709320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta-analysis.
    Cheung CKM; Law MF; Chao DC; Wong SH; Ho R; Chao ACW; Lai JWY; Chan TYT; Tam MTK; Lau SLF; Tam THC
    J Dig Dis; 2020 Mar; 21(3):160-169. PubMed ID: 32040243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.
    Kanaan N; Kabamba B; Maréchal C; Pirson Y; Beguin C; Goffin E; Hassoun Z
    J Clin Virol; 2012 Nov; 55(3):233-8. PubMed ID: 22921412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.
    Duhart BT; Honaker MR; Shokouh-Amiri MH; Riely CA; Vera SR; Taylor SL; Al-jedai AH; Gaber AO
    Transpl Infect Dis; 2003 Sep; 5(3):126-31. PubMed ID: 14617300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
    Zappulo E; Nicolini LA; Di Grazia C; Dominietto A; Lamparelli T; Gualandi F; Caligiuri P; Bruzzone B; Angelucci E; Viscoli C; Mikulska M
    Infection; 2019 Feb; 47(1):59-65. PubMed ID: 30232604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients.
    Álvarez-López P; Riveiro-Barciela M; Oleas-Vega D; Flores-Cortes C; Román A; Perelló M; Berastegui C; Castells L; Esteban R; Buti M
    Medicine (Baltimore); 2020 Feb; 99(9):e19407. PubMed ID: 32118794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-limited HBV infection of the recipient does not reactivate after liver transplantation: Observations from a 30-year liver transplant program.
    Ossami Saidy RR; Demir M; Nibbe P; Dobrindt EM; Oellinger R; Schoening W; Pratschke J; Eurich D
    Transpl Infect Dis; 2021 Feb; 23(1):e13436. PubMed ID: 32748492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter evaluation of hepatitis B reactivation with and without antiviral prophylaxis after kidney transplantation.
    Shaikh SA; Kahn J; Aksentijevic A; Kawewat-Ho P; Bixby A; Rendulic T; Park JM
    Transpl Infect Dis; 2022 Feb; 24(1):e13751. PubMed ID: 34725887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.